Abstract
Chemokines secreted from different cellular components of bone marrow (BM) play an important role in the formation of the BM niche system. The hematopoietic stem cell (HSC) pool located in specialized anatomical sites within the BM is subjected to a complex network of chemokines, such that the produced chemokines affect the fate of these cells. Expression of different chemokine receptors on leukemic stem cells (LSCs) uncovers the critical role of chemokines in the maintenance, survival and fate of these cells in the leukemic niche. As a pre-metastatic niche rich in a variety of chemokines, the BM niche is turned into a locus of tumor cell development and division. The chemokine receptors expressed on the surface of metastatic cells lead to their metastasis and homing to the BM niche. Knowledge of chemokines and their receptors leads to the production of various therapeutic antagonists at chemokine receptors expressed on leukemic and tumor cells, enabling interference with chemokine function as a therapeutic tool. New findings suggest that miRNAs, with their specific inhibitory function, affect the ability of producing and expressing chemokines and chemokine receptors. This review focuses on the emerging role of chemokines and their receptors in normal and pathologic conditions of the BM niche, and also discusses the new therapeutic methods with this background.
Similar content being viewed by others
References
Abroun S (2008) Chemokines in homeostasis and cancers. Yakhteh Med J 10:155–166
Arabanian LS, Fierro FA, Stölzel F, Heder C, Poitz DM, Strasser RH, Wobus M, Bornhäuser M, Ferrer RA, Platzbecker U (2014) miRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells. Haematol Haematol 99:997–1005, 2013.097675
Asirvatham AJ, Magner WJ, Tomasi TB (2009) miRNA regulation of cytokine genes. Cytokine 45:58–69
Azizidoost S, Babashah S, Rahim F, Shahjahani M, Saki N (2013) Bone marrow neoplastic niche in leukemia. Hematology 19:232–238
Babashah S, Soleimani M (2011) The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47:1127–1137
Balkwill F (2004) Cancer and the chemokine network. Nat Rev Cancer 4:540–550
Balkwill FR (2012) The chemokine system and cancer. J Pathol 226:148–157
Bast RC Jr, Urban N, Shridhar V, Smith D, Zhang Z, Skates S, Lu K, Liu J, Fishman D, Mills G (2002) Early detection of ovarian cancer: promise and reality. Cancer Treat Res 107:61–97
Bissels U, Bosio A, Wagner W (2012) MicroRNAs are shaping the hematopoietic landscape. Haematologica 97:160–167
Borish LC, Steinke JW (2003) Cytokines and chemokines. J Allergy Clin Immunol 111(2):S460–S475
Browne G, Taipaleenmäki H, Stein GS, Stein JL, Lian JB (2014) MicroRNAs in the control of metastatic bone disease. Trends Endocrinol Metab 25:6
Broxmeyer HE (2008) Chemokines in hematopoiesis. Curr Opin Hematol 15:49–58
Burger J, Peled A (2009) CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers. Leukemia 23:43–52
Bydlowski SP, Levy D, Ruiz JM, Pereira J (2013) Hematopoietic stem cell niche: role in normal and malignant hematopoiesis: In: Alimoghaddam K (ed) Stem cell biology in normal life and diseases, vol V.InTech, Rijeka, pp 17–32
Calvi LM, Link DC (2014) Cellular complexity of the bone marrow hematopoietic stem cell niche. Calcif Tissue Int 94:112–124
Cao H, Oteiza A, Nilsson SK (2013) Understanding the role of the microenvironment during definitive hemopoietic development. Exp Hematol 41:761–768
Chinni SR, Sivalogan S, Dong Z, Deng X, Bonfil RD, Cher ML (2006) CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: the role of bone microenvironment‐associated CXCL12. Prostate 66:32–48
Choong ML, Yong YP, Tan AC, Luo B, Lodish HF (2004) LIX: a chemokine with a role in hematopoietic stem cells maintenance. Cytokine 25:239–245
Chotinantakul K, Leeanansaksiri W (2012) Hematopoietic stem cell development, niches, and signaling pathways. Bone Marrow Res 2012:270425
Clark EA, Kalomoiris S, Nolta JA, Fierro FA (2014) Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells 32:1074–1082
Crews LA, Jamieson CH (2013) Selective elimination of leukemia stem cells: hitting a moving target. Cancer Lett 338:15–22
Deng L, Chen N, Li Y, Zheng H, Lei Q (2010) CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochimica et Biophysica Acta (BBA)-reviews on. Cancer 1806:42–49
Doan P, Chute J (2012) The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia 26:54–62
Ehninger A, Trumpp A (2011) The bone marrow stem cell niche grows up: mesenchymal stem cells and macrophages move in. J Exp Med 208:421–428
Ema H, Suda T (2012) Two anatomically distinct niches regulate stem cell activity. Blood 120:2174–2181
Grassi F, Piacentini A, Cristino S, Toneguzzi S, Cavallo C, Facchini A, Lisignoli G (2003) Human osteoclasts express different CXC chemokines depending on cell culture substrate: molecular and immunocytochemical evidence of high levels of CXCL10 and CXCL12. Histochem Cell Biol 120:391–400
Graves DT, Jiang Y, Valente AJ (1999) The expression of monocyte chemoattractant protein-1 and other chemokines by osteoblasts. Front Biosci 4:D571–D580
Hanoun M, Frenette PS (2013) This niche is a maze; an amazing niche. Cell Stem Cell 12:391–392
Haylock DN, Nilsson SK (2006) Osteopontin: a bridge between bone and blood. Br J Haematol 134:467–474
Hoggatt J, Pelus LM (2011) Mobilization of hematopoietic stem cells from the bone marrow niche to the blood compartment. Stem Cell Res Ther 2:13
Hoggatt J, Scadden DT (2012) The stem cell niche: tissue physiology at a single cell level. J Clin Invest 122:3029
Huang X, Cho S, Spangrude G (2007) Hematopoietic stem cells: generation and self-renewal. Cell Death Differ 14:1851–1859
Jamieson WL, Shimizu S, D’Ambrosio JA, Meucci O, Fatatis A (2008) CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res 68:1715–1722
Jamieson-Gladney WL, Zhang Y, Fong AM, Meucci O, Fatatis A (2011) The chemokine receptor CX3CR1 is directly involved in the arrest of breast cancer cells to the skeleton. Breast Cancer Res 13:R91
Jin T, Xu X, Hereld D (2008) Chemotaxis, chemokine receptors and human disease. Cytokine 44:1–8
Johnson EL, Singh S, Johnson-Holiday C, Singh UP, Partridge EE, Datta MW, Lillard JW (2006) CCL25-CCR9 axis role in ovarian cancer cell metastasis and survival. Proc Am Assoc Cancer Res 2006:70
Kalinkovich A, Spiegel A, Shivtiel S, Kollet O, Jordaney N, Piacibello W, Lapidot T (2009) Blood-forming stem cells are nervous: direct and indirect regulation of immature human CD34+ cells by the nervous system. Brain Behav Immun 23:1059–1065
Kaplan RN, Psaila B, Lyden D (2006) Bone marrow cells in the ‘pre-metastatic niche’: within bone and beyond. Cancer Metastasis Rev 25:521–529
Kaplan RN, Psaila B, Lyden D (2007) Niche-to-niche migration of bone-marrow-derived cells. Trends Mol Med 13:72–81
Karnoub AE, Weinberg RA (2007) Chemokine networks and breast cancer metastasis. Breast Dis 26:75–85
Kim S-J, Shin J-Y, Lee K-D, Bae Y-K, Sung KW, Nam SJ, Chun K-H (2012) MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of CC chemokine receptor type 7. Breast Cancer Res 14:R14
Klarenbeek A, Maussang D, Blanchetot C, Saunders M, van der Woning S, Smit M, de Haard H, Hofman E (2013) Targeting chemokines and chemokine receptors with antibodies. Drug Discov Today Technol 9:e237–e244
Krause DS, Scadden DT, Preffer FI (2013) The hematopoietic stem cell niche—home for friend and foe? Cytometry B 84:7–20
Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597–610
Kulbe H, Levinson NR, Balkwill F, Wilson JL (2004) The chemokine network in cancer-much more than directing cell movement. Int J Dev Biol 48:489–496
Kunisaki Y, Bruns I, Scheiermann C, Ahmed J, Pinho S, Zhang D, Mizoguchi T, Wei Q, Lucas D, Ito K (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502:637–643
Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, Petrucci E, Biffoni M, Nuzzolo ER, Billi M, Foà R (2008) A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 10:788–801
Lean JM, Murphy C, Fuller K, Chambers TJ (2002) CCL9/MIP‐1γ and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts. J Cell Biochem 87:386–393
Liang Z, Bian X, Shim H (2014) Inhibition of breast cancer metastasis with microRNA-302a by downregulation of CXCR4 expression. Breast Cancer Res Treat 146:535–542
Lim PK, Bliss SA, Patel SA, Taborga M, Dave MA, Gregory LA, Greco SJ, Bryan M, Patel PS, Rameshwar P (2011) Gap junction–mediated import of MicroRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res 71:1550–1560
Lisignoli G, Toneguzzi S, Piacentini A, Cattini L, Lenti A, Tschon M, Cristino S, Grassi F, Facchini A (2003) Human osteoblasts express functional CXC chemokine receptors 3 and 5: activation by their ligands, CXCL10 and CXCL13, significantly induces alkaline phosphatase and β‐N‐acetylhexosaminidase release. J Cell Physiol 194:71–79
Liu Z, Sall A, Yang D (2008) MicroRNA: an emerging therapeutic target and intervention tool. Int J Mol Sci 9:978–999
López-Giral S, Quintana NE, Cabrerizo M, Alfonso-Pérez M, Sala-Valdés M, de Soria VGG, Fernández-Rañada JM, Fernández-Ruiz E, Muñoz C (2004) Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination. J Leukoc Biol 76:462–471
Lu X, Kang Y (2009) Chemokine (CC motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone. J Biol Chem 284:29087–29096
Lu Y, Chen Q, Corey E, Xie W, Fan J, Mizokami A, Zhang J (2009) Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone. Clin Exp Metastasis 26:161–169
Luis T, Killmann NM, Staal F (2012) Signal transduction pathways regulating hematopoietic stem cell biology: introduction to a series of spotlight reviews. Leukemia 26:86–90
Mantovani A (1999) The chemokine system: redundancy for robust outputs. Immunol Today 20:254–257
Mantovani A, Savino B, Locati M, Zammataro L, Allavena P, Bonecchi R (2010) The chemokine system in cancer biology and therapy. Cytokine Growth Factor Rev 21:27–39
Meads MB, Hazlehurst LA, Dalton WS (2008) The bone marrow microenvironment as a tumor sanctuary and contributor to drug resistance. Clin Cancer Res 14:2519–2526
Morrison SJ, Scadden DT (2014) The bone marrow niche for haematopoietic stem cells. Nature 505:327–334
Motabi IH, DiPersio JF (2012) Advances in stem cell mobilization. Blood Rev 26:267–278
Müller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50–56
Musrap N, Diamandis EP (2012) Revisiting the complexity of the ovarian cancer microenvironment—clinical implications for treatment strategies. Mol Cancer Res 10:1254–1264
Nakamura ES, Koizumi K, Kobayashi M, Saitoh Y, Arita Y, Nakayama T, Sakurai H, Yoshie O, Saiki I (2006) RANKL-induced CCL22/macrophage-derived chemokine produced from osteoclasts potentially promotes the bone metastasis of lung cancer expressing its receptor CCR4. Clin Exp Metastasis 23:9–18
Nwajei F, Konopleva M (2013) The bone marrow microenvironment as niche retreats for hematopoietic and leukemic stem cells. Adv Hematol 2013, 953982
Papachristou DJ, Basdra EK, Papavassiliou AG (2012) Bone metastases: molecular mechanisms and novel therapeutic interventions. Med Res Rev 32:611–636
Peled A, Tavor S (2013) Role of CXCR4 in the pathogenesis of acute myeloid leukemia. Theranostics 3:34
Pelus LM, Fukuda S (2006) Peripheral blood stem cell mobilization: the CXCR2 ligand GROβ rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties. Exp Hematol 34:1010–1020
Pelus L, Fukuda S (2008) Chemokine-mobilized adult stem cells; defining a better hematopoietic graft. Leukemia 22:466–473
Pelus LM, Horowitz D, Cooper SC, King AG (2002) Peripheral blood stem cell mobilization: a role for CXC chemokines. Crit Rev Oncol Hematol 43:257–275
Pillai MM, Yang X, Balakrishnan I, Bemis L, Torok-Storb B (2010) MiR-886-3p down regulates CXCL12 (SDF1) expression in human marrow stromal cells. PLoS ONE 5:e14304
Pontikoglou C, Deschaseaux F, Sensebé L, Papadaki HA (2011) Bone marrow mesenchymal stem cells: biological properties and their role in hematopoiesis and hematopoietic stem cell transplantation. Stem Cell Rev Rep 7:569–589
Rankin SM (2012) Chemokines and adult bone marrow stem cells. Immunol Lett 145:47–54
Reiland J, Furcht LT, McCarthy JB (1999) CXC‐chemokines stimulate invasion and chemotaxis in prostate carcinoma cells through the CXCR2 receptor. Prostate 41:78–88
Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217–242
Ruddy MJ, Shen F, Smith JB, Sharma A, Gaffen SL (2004) Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 76:135–144
Saba F, Soleimani M, Atashi A, Mortaz E, Shahjahani M, Roshandel E, Jaseb K, Saki N (2013) The role of the nervous system in hematopoietic stem cell mobilization. Lab Hematol 19:8–16
Saki N, Abroun S, Hagh MF, Asgharei F (2011) Neoplastic bone marrow niche: hematopoietic and mesenchymal stem cells. Cell J (Yakhteh) 13:131
Sarvaiya PJ, Guo D, Ulasov I, Gabikian P, Lesniak MS (2013) Chemokines in tumor progression and metastasis. Oncotarget 4:2171
Sceneay J, Smyth MJ, Möller A (2013) The pre-metastatic niche: finding common ground. Cancer Metastasis Rev 32:449–464
Schepers K, Pietras EM, Reynaud D, Flach J, Binnewies M, Garg T, Wagers AJ, Hsiao EC, Passegué E (2013) Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13:285–299
Schinköthe T, Bloch W, Schmidt A (2008) In vitro secreting profile of human mesenchymal stem cells. Stem Cells Dev 17:199–206
Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR (2001) Epithelial cancer cell migration a role for chemokine receptors? Cancer Res 61:4961–4965
Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S, Bridger G, Balkwill FR (2002) Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62:5930–5938
Shi C, Jia T, Mendez-Ferrer S, Hohl TM, Serbina NV, Lipuma L, Leiner I, Li MO, Frenette PS, Pamer EG (2011) Bone marrow mesenchymal stem and progenitor cells induce monocyte emigration in response to circulating toll-like receptor ligands. Immunity 34:590–601
Shi J, Wei Y, Xia J, Wang S, Wu J, Chen F, Huang G, Chen J (2014) CXCL12-CXCR4 contributes to the implication of bone marrow in cancer metastasis. Future Oncol 10:749–759
Shiozawa Y, Pienta KJ, Taichman RS (2011) Hematopoietic stem cell niche is a potential therapeutic target for bone metastatic tumors. Clin Cancer Res 17:5553–5558
Silberstein LE, Lin CP (2013) A New image of the hematopoietic stem cell vascular niche. Cell Stem Cell 13:514–516
Singh S, Singh UP, Stiles JK, Grizzle WE, Lillard JW (2004) Expression and functional role of CCR9 in prostate cancer cell migration and invasion. Clin Cancer Res 10:8743–8750
Smith JN, Calvi LM (2013) Concise review: current concepts in bone marrow microenvironmental regulation of hematopoietic stem and progenitor cells. Stem Cells 31:1044–1050
Su L, Zhang J, Xu H, Wang Y, Chu Y, Liu R, Xiong S (2005) Differential expression of CXCR4 is associated with the metastatic potential of human non–small cell lung cancer cells. Clin Cancer Res 11:8273–8280
Sun YX, Wang J, Shelburne CE, Lopatin DE, Chinnaiyan AM, Rubin MA, Pienta KJ, Taichman RS (2003) Expression of CXCR4 and CXCL12 (SDF‐1) in human prostate cancers (PCa) in vivo. J Cell Biochem 89:462–473
Taubenberger AV (2014) In vitro microenvironments to study breast cancer bone colonisation. Adv Drug Deliv Rev 79-80C:135–144
Tzoneva G, Ferrando AA (2012) Recent advances on NOTCH signaling in T-ALL. CurrTop Microbiol Immunol 360:163–182
Ugarte F, Forsberg EC (2013) Haematopoietic stem cell niches: new insights inspire new questions. EMBO J 32:2535–2547
Vaday GG, Peehl DM, Kadam PA, Lawrence DM (2006) Expression of CCL5 (RANTES) and CCR5 in prostate cancer. Prostate 66:124–134
Velasco-Velázquez M, Pestell RG (2013) The CCL5/CCR5 axis promotes metastasis in basal breast cancer. Oncoimmunology 2:e23660–e23660
Wang D, Liu D, Gao J, Liu M, Liu S, Jiang M, Liu Y, Zheng D (2013) TRAIL‐induced miR‐146a expression suppresses CXCR4‐mediated human breast cancer migration. FEBS J 280:3340–3353
Winkler IG, Lévesque J-P (2006) Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 34:996–1009
Yamazaki S, Ema H, Karlsson G, Yamaguchi T, Miyoshi H, Shioda S, Taketo MM, Karlsson S, Iwama A, Nakauchi H (2011) Nonmyelinating Schwann cells maintain hematopoietic stem cell hibernation in the bone marrow niche. Cell 147:1146–1158
Yin T, Li L (2006) The stem cell niches in bone. J Clin Investig 116:1195–1201
Yoon K-A, Cho H-S, Shin H-I, Cho J-Y (2012) Differential regulation of CXCL5 by FGF2 in osteoblastic and endothelial niche cells supports hematopoietic stem cell migration. Stem Cells Dev 21:3391–3402
Youn BS, Mantel C, Broxmeyer HE (2000) Chemokines, chemokine receptors and hematopoiesis. Immunol Rev 177:150–174
Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci U S A 107:8231–8236
Zhang Y, Yang P, Wang X-F (2013) Microenvironmental regulation of cancer metastasis by mirnas. Trends Cell Biol 24:153–160
Acknowledgments
We are grateful to all our colleagues in the Health Research Institute, Research Center of Thalassemia & Hemoglobinopathy.
Authors’ contributions
Najmaldin Saki and Richard E. Kast conceived the manuscript and revised it; Neda Ketabchi, Mohammad Shahjahani and Ahmad Ahmadzadeh wrote the manuscript; Kaveh Jaseb and Saeid Shahrabi contributors helped writing final version of manuscript.
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ahmadzadeh, A., Kast, R.E., Ketabchi, N. et al. Regulatory effect of chemokines in bone marrow niche. Cell Tissue Res 361, 401–410 (2015). https://doi.org/10.1007/s00441-015-2129-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00441-015-2129-4